MAO-A, MAO-B, and MAO-A/B inhibitors have been shown to significantly change cytokine and chemokine expression in a number of cell culture and disease models such as depression, Parkinson’s, ischemia/reperfusion tissue injury, periodontal disease, and smoke-induced lung injury (Table 2). This evidence concerns the gene MAOB and depressive symptom measurement.